Scott Whitaker, AdvaMed’s President & CEO, recently joined host David Westin on Bloomberg Radio’s “Balance of Power” program to provide a national audience with an update on how the medical technology industry has mobilized to combat the COVID-19 pandemic.
Top News
Blog Post | March 31, 2020
Press Release | March 27, 2020
WASHINGTON, D.C. – Today, AdvaMed President and CEO Scott Whitaker released a statement applauding congressional passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
Press Release | March 24, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today sent a letter to the Federal Emergency Management Agency (FEMA) and the administration calling for centralization of procurement and allocation decision-making for medical ventilators to address the coronanvius pandemic and help ensure appropriate access to health care providers and patients.
Events
April
23
April 23, 2020 to April 24, 2020
| Washington, DC COVID-19 Update
After much consideration and discussion, AdvaMed has made the decision to cancel the 13th Annual FDA/AdvaMed Medical Devices and Diagnostics Statistical Issues Conference scheduled... Read More
May
14
May 14, 2020 to May 15, 2020
| Washington, DC COVID-19 Update
After much consideration and discussion, AdvaMed has made the decision to cancel the Advertising and Promotion of Medical Devices Conference scheduled for May 14-15, 2020 at the... Read More
May
19
May 19, 2020 to May 20, 2020
| Los Angeles, CA COVID-19 Update
After much consideration and discussion, AdvaMed has made the decision to cancel The Digital MedTech Conference scheduled for May 19-20, 2020 at the Millenium Biltmore Hotel in Los... Read More
June
09
June 9, 2020 | Washington, DC
Hear from women CEOs, senior leaders and a member of congress on how they are shaping the future of our industry. Register now to receive early bird pricing while we finalize this exciting program.... Read More
October
05
October 5, 2020 to October 7, 2020
| Toronto, Canada
From September 23–25, 2019, more than 3,300 of the world’s top medtech executives gathered in Boston, MA, for the leading event in our industry — The MedTech Conference. Join us again as we take... Read More
Featured Video
Millions of lives are improved every day because of advancements in medical technology. We empower patients to share their experiences with medical technology and inspire patients across the globe. By raising our voices together, we are connecting with others who understand the value of medical technology and its life-changing impact. We are survivors. We are innovation. We are the story of medtech.
Industry News
Martinez, CA, USA – March 26, 2020 – Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA.
Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical cases improved lung function and rapid reduction of drug-resistant bacterial pathogens occurred with Seraph 100...
HAYWARD, Calif.--RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* to treat all stages of cancer today announced it has received marketing clearance from the U.S. Food & Drug Administration (FDA) for stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT) for its RefleXion™ X1 machine.
“We are at the forefront of an enormous change in expanding the use of radiotherapy from a...
BOSTON and SYDNEY — 28 January 2020 — GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce the first patient in the United States (U.S.) STEP-1 clinical trial has been enrolled at Michigan Medicine in Ann Arbor, Michigan.
Michigan Medicine is one of five clinical study sites for the STEP-1 trial; the site is led by principal investigator Allison R. Schulman M.D., M.P.H., assistant professor of...
SAN JOSE, Calif., December 3, 2019 — Venclose Inc., a privately-held Silicon Valley medical device company focused on innovative treatment procedures for venous reflux disease today announced it has closed a Series C funding led by Ally Bridge Group (ABG). ABG is a global life science-focused group with a successful investment record globally in supporting high-growth innovative life science companies.
“Securing this financing further confirms continued investor confidence in Venclose’s...
Where Women Work
Prime employers for women BD and Medtronic both attended the prestigious MedTech Conference and addressed industry delegates.
The conference saw more than 3,300 of the world’s top medical technology executives gather in Boston, USA, for educational programming, valuable networking and business development opportunities.
Positioning corporate diversity and inclusion for success
BD’s VP of Inclusion & Diversity Johnel Evans joined other executive leaders on a panel discussing positioning...
Twitter Feed
March 30, 2020 - 3:01pm
The #MedTech industry is working to boost #PPE production and avoid shortages. Even in the event of a spike in… https://t.co/05pBOsLPUY
March 30, 2020 - 1:50pm
RT @MedtronicCEO: Our PB 560 Ventilator is being open sourced. @Medtronic design and specs will be available to be manufactured by an… https://t.co/VOYSHYVeaU